DELX (Delex Healthcare Group) Other Current Payables: $0.00 Mil (As of Sep. 2023)


What is Delex Healthcare Group Other Current Payables?

Delex Healthcare Group DELX Other Current Payables is $0.00 Mil as of Sep. 2023.

Delex Healthcare Group's Other Current Payables for the quarter that ended in Sep. 2023 was $0.00 Mil.

Delex Healthcare Group Other Current Payables Related Terms

Delex Healthcare Group Other Current Payables Historical Data

* Premium members only.

The historical data trend for Delex Healthcare Group's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Delex Healthcare Group Other Current Payables Chart

Delex Healthcare Group Annual Data
Trend
Other Current Payables

Delex Healthcare Group Semi-Annual Data
Sep22 Sep23
Other Current Payables 0.00 0.00

Delex Healthcare Group Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $0.00 Mil mean?
Delex Healthcare Group (DELX) has a Other Current Payables of $0.00 Mil as of Sep. 2023. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Delex Healthcare Group and its competitors.
Is Delex Healthcare Group's Other Current Payables too high?
Delex Healthcare Group's current Other Current Payables is $0.00 Mil.
How does Delex Healthcare Group's Other Current Payables compare to PIAC and PWM?
Delex Healthcare Group's Other Current Payables of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Drug Manufacturers company?
A good Other Current Payables depends on the Drug Manufacturers industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Delex Healthcare Group and its competitors. Delex Healthcare Group's current Other Current Payables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delex Healthcare Group stock overvalued right now?
Delex Healthcare Group (DELX) has a current Other Current Payables of $0.00 Mil. The current Other Current Payables is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Delex Healthcare Group (DELX), the current Other Current Payables is $0.00 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Delex Healthcare Group Business Description

Address Carnation Street, Blk 4, Lot 4, Cor., Magnolia, Novaliches, Quezon City, PHL, 1109
Delex Healthcare Group Inc is a healthcare-focused organization engaged in pharmaceutical and healthcare-related businesses.